PREGNANCY OUTCOMES IN PATIENTS WITH AND WITHOUT CHR ONICENDOMETRITIS UNDERGOING IN VITRO FERTILIZATION AT HAI PHONG OBSTETRICS AND GYNECOLOGY HOSPITAL

Thị Minh Phương Vũ 1,2, , Văn Tâm Vũ 1, Thị Bích Loan Vũ 1, Vũ Dũng Lưu 1, Ngọc Thành Cao2
1 Hai Phong Obstetrics and Pediatrics Hospital
2 Hue University of Medicine and Pharmacy

Main Article Content

Abstract

Objective: To determine the prevalence of chronic endometritis (CE) and evaluate pregnancy outcomes in patients with and without this condition undergoing in vitro fertilization (IVF).


Subjects and Methods: A prospective cohort study was conducted on 103 patients undergoing IVF at Hai Phong Obstetrics and Gynecology Hospital from August 2024 to August 2025. CE was diagnosed based on CD138 immunohistochemical staining (≥5 plasma cells per 10 high-power fields). Patients were divided into CE and non-CE groups. The CE group received antibiotic treatment prior to embryo transfer. Pregnancy outcomes were compared between the two groups.


Results: The prevalence of CE was 37.9% (39/103). There was no statistically significant difference between the two groups regarding IVF cycle characteristics and embryo transfer characteristics (p > 0.05). The pregnancy rate in the treated CE group was higher than in the non-CE group (71.1% vs. 55.7%), although the difference was not statistically significant (p > 0.05). Clinical pregnancy and ongoing pregnancy rates in the treated CE group were 68.4% and 60.5%, respectively, significantly higher than those in the non-CE group (47.5% and 39.3%) with p = 0.04. Subgroup analysis showed that patients with mild CE (5 ≤ CD138 < 10) had the highest pregnancy outcomes.


Conclusion: Chronic endometritis is relatively prevalent among infertile patients undergoing IVF. Screening and treatment prior to embryo transfer may improve IVF outcomes, particularly clinical and ongoing pregnancy rates.

Article Details

References

1. Singh N, Sethi A. Endometritis - Diagnosis,Treatment and its impact on fertility - A Scoping Review. JBRA Assist Reprod. 2022;26(3):538-46.
2. Kitaya K, Yasuo T. Aberrant expression of selectin E, CXCL1, and CXCL13 in chronic endometritis. Mod Pathol. 2010;23(8):1136-46.
3. Santoro A, Travaglino A, Inzani F, Angelico G, Raffone A, Maruotti GM, et al. The Role of Plasma Cells as a Marker of Chronic Endometritis: A Systematic Review and Meta-Analysis. Biomedicines. 2023;11(6).
4. Cicinelli E, Matteo M, Tinelli R, Lepera A, Alfonso R, Indraccolo U, et al. Prevalence of chronic endometritis in repeated unexplained implantation failure and the IVF success rate after antibiotic therapy. Hum Reprod. 2015;30(2):323-30.
5. Dang J, Xiao X, Li M. Correlation of hysteroscopic findings of chronic endometritis with CD138 immunohistochemistry and their correlation with pregnancy outcomes. J Assist Reprod Genet. 2024;41(9):2477-83.
6. Demirdag E, Guler I, Cevher Akdulum MF, Sahin E, Erdem O, Erdem A, et al. Subsequent IVF outcomes following antibiotic therapy for chronic endometritis in patients with recurrent implantation failure. J Obstet Gynaecol Res. 2021;47(12):4350-6.
7. Vitagliano A, Saccardi C, Noventa M, Di Spiezio Sardo A, Saccone G, Cicinelli E, et al. Effects of chronic endometritis therapy on in vitro fertilization outcome in women with repeated implantation failure: a systematic review and meta-analysis. Fertil Steril. 2018;110(1):103-12.e1.
8. Song D, Feng X, Zhang Q, Xia E, Xiao Y, Xie W, et al. Prevalence and confounders of chronic endometritis in premenopausal women with abnormal bleeding or reproductive failure. Reprod Biomed Online. 2018;36(1):78-83.